Literature DB >> 3888678

Ultrasonic findings in polycystic ovarian disease.

L F Orsini, S Venturoli, R Lorusso, V Pluchinotta, R Paradisi, L Bovicelli.   

Abstract

The uterus and ovaries of 50 patients with polycystic ovarian disease (PCOD) and 30 eumenorrheic women were studied with a real-time ultrasound mechanical sector scanner. Uterine and ovarian volumes (UV and OV) and the OV/UV ratio were calculated, and ovarian morphology was classified as prevalently solid and cystic. Both ovaries were displayed in 44 of the PCOD and in 25 of the normal patients and appeared bilaterally solid, cystic, or with different morphology, respectively, in 43.2%, 47.7%, and 9.1% of cases in the former group and in 76%, 20%, and 4% in the latter group. Statistically significant differences between normal and PCOD patients were found in OV, UV, and OV/UV ratio. Bilaterally enlarged ovaries with multiple tiny cysts, the classic ultrasonographic picture of the polycystic ovary, were found in only 16 (36.3%) of the PCOD cases, while 34 (77.3%) had an OV/UV ratio greater than 1 standard deviation above the mean. Four ultrasonographic ovarian patterns were observed in the PCOD patients: enlarged cystic; enlarged solid; normal-sized cystic; and normal-sized solid. These findings emphasize the need for a reconsideration of the ultrasonographic criteria of PCOD.

Entities:  

Mesh:

Year:  1985        PMID: 3888678     DOI: 10.1016/s0015-0282(16)48552-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.

Authors:  R Paradisi; S Venturoli; R Pasquali; M Capelli; E Porcu; R Fabbri; C Flamigni
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

2.  The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.

Authors:  D Romualdi; V Versace; V Tagliaferri; S De Cicco; V Immediata; R Apa; M Guido; A Lanzone
Journal:  J Endocrinol Invest       Date:  2019-03-07       Impact factor: 4.256

3.  Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome.

Authors:  A Gambineri; L Patton; O Prontera; F Fanelli; W Ciampaglia; G E Cognigni; U Pagotto; R Pasquali
Journal:  J Endocrinol Invest       Date:  2011-05-17       Impact factor: 4.256

4.  The association between in utero exposure to maternal psychological stress and female reproductive function in adolescence: A prospective cohort study.

Authors:  E V Bräuner; T Koch; D A Doherty; J E Dickinson; A Juul; R Hart; M Hickey
Journal:  Compr Psychoneuroendocrinol       Date:  2020-12-18

5.  Anti-androgen treatment increases circulating ghrelin levels in obese women with polycystic ovary syndrome.

Authors:  A Gambineri; U Pagotto; M Tschöp; V Vicennati; E Manicardi; A Carcello; M Cacciari; R De Iasio; R Pasquali
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

6.  The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.

Authors:  R Pasquali; F Casimirri; V Balestra; R Flamia; N Melchionda; R Fabbri; L Barbara
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

7.  Endocrine and clinical effects of spironolactone in female hyperandrogenism.

Authors:  R Siegberg; P Ylöstalo; T Laatikainen; R Pelkonen; U H Stenman
Journal:  Arch Gynecol       Date:  1987

8.  Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.

Authors:  Chao-Yan Yue; Lou-Kai-Yi Lu; Meng Li; Qian-Lan Zhang; Chun-Mei Ying
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.